BioSpace News Archive

Trident Brands Inc. (OTCQB: TDNT) today announced that a study using their Brain Armor® brand of neuro-nutrition supplements has been published.

SciSparc Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced a series of rebranding processes.

Akorn Operating Company LLC (Akorn), a leading specialty pharmaceutical company, announced that it received approval of its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for Loteprednol Etabonate Ophthalmic Gel, 0.5%.

Health technology leader continues to climb list, up 21 spots from last ranking

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced that in 2020 it entered into agreements with 11 new companies.

Rite Aid is proud to partner with the federal government as an inaugural participant in the Federal Retail Pharmacy Program.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Qatar Ministry of Public Health has issued an emergency use authorization for COVID-19 Vaccine Moderna.

Centinel Spine, LLC, the largest privately-held spine company focused on anterior column reconstruction, announced its novel STALIF M FLX™ 3D-Printed ALIF device was listed by SPINEMarketGroup as the top ALIF 3D-printed cage.

Calgary, Alberta--(Newsfile Corp. - February 11, 2021) - Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce it has contracted Protocol First to provide it with source document verification services.

Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced, today that it will issue its financial results for the fourth quarter and fiscal year ended November 30, 2020 on Thursday, February 25, 2021. A conference call will be held on February 25, 2021 at 8:30 a.m. (ET) to discuss the results.